Certain medications that reduce the risk of breast cancer now must be covered under Obamacare.
The Department of Health and Human Services issued guidance Thursday saying that most insurance plans are required to cover the chemo-preventative drugs tamoxifen and raloxifene without co-pays or out-of-pocket expenses for women with an increased risk of developing breast cancer.
The Obama administration issued the clarification after questions arose about whether these medications count as preventative care, HHS Secretary Kathleen Sebelius and Florida Democratic Rep. Debbie Wasserman Schultz — a breast cancer survivor — wrote in a blog post Thursday.
The United States Preventive Services Task Force, an independent panel of experts selected by HHS, revised its recommendation in September to suggest the medications be available to women at high risk for the disease.
There is an exception to HHS’ policy, however: Grandfathered plans — those that existed prior to the passage of the Affordable Care Act — are not subject to the same requirements.
The National Cancer Institute estimates that in 2013 there were 232,340 new cases of breast cancer in women, and 2,240 in men. Cause and prevention of breast cancer in men is currently less well understood.
Preventative screening is a point of emphasis for the Affordable Care Act, as the law aims to promote such treatments in a bid to cut total health spending. But what treatments and medications meet the law’s criteria for preventative care — and which ones get an inclusion mandate in insurance plans — is a point of contention for various medical constituencies trying to get their treatments under Obamacare’s umbrella.
What We're Following See More »
The Commission on Presidential Debates put out a statement today that gives credence to Donald Trump's claims that he had a bad microphone on Monday night. "Regarding the first debate, there were issues regarding Donald Trump's audio that affected the sound level in the debate hall," read the statement in its entirety.
"A video of Donald Trump testifying under oath about his provocative rhetoric about Mexicans and other Latinos is set to go public" as soon as today. "Trump gave the testimony in June at a law office in Washington in connection with one of two lawsuits he filed last year after prominent chefs reacted to the controversy over his remarks by pulling out of plans to open restaurants at his new D.C. hotel. D.C. Superior Court Judge Brian Holeman said in an order issued Thursday evening that fears the testimony might show up in campaign commercials were no basis to keep the public from seeing the video."
No matter that his recall of foreign leaders leaves something to be desired, Gary Johnson is the choice of the Chicago Tribune's editorial board. The editors argue that Donald Trump couldn't do the job of president, while hitting Hillary Clinton for "her intent to greatly increase federal spending and taxation, and serious questions about honesty and trust." Which leaves them with Johnson. "Every American who casts a vote for him is standing for principles," they write, "and can be proud of that vote. Yes, proud of a candidate in 2016."
Speaking at the funeral of former Israeli Prime Minister Shimon Peres, President Obama "compared Peres to 'other giants of the 20th century' such as Nelson Mandela and Queen Elizabeth who 'find no need to posture or traffic in what's popular in the moment.'" Among the 6,000 mourners at the service was Palestinian President Mahmoud Abbas. Obama called Abbas's presence a sign of the "unfinished business of peace" in the region.